PHARMA News

PHARMA: Change in Risk Committee - ENCIK AHMAD SHAHREDZUAN MOHD SHARIFF

Oct 1 17:44

PHARMA: Change in Nomination and Remuneration Committee - ENCIK AHMAD SHAHREDZUAN BIN MOHD SHARIFF

Oct 1 17:44

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Oct 1 12:45

PHARMA: OTHERS

Sep 23 12:45

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Sep 2 17:33

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Aug 1 17:38

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Jul 1 12:48

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Jun 5 12:47

Forbid of Direct Business Transaction (DBT) Due to Rule 10.10(3)

May 27 13:58

PHARMA: AUDIT REPORT - MODIFIED OPINION / MATERIAL UNCERTAINTY RELATED TO GOING CONCERN : MATERIAL UNCERTAINTY RELATED TO GOING CONCERN

May 8 19:19

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

May 2 17:33

PHARMA: TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RECURRENT RELATED PARTY TRANSACTIONS

Apr 23 13:06

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Apr 2 18:07

PHARMA: Change in Risk Committee - DATO' DR FARIDAH ARYANI BINTI MD YUSOF

Mar 27 13:11

PHARMA: Change in Risk Committee - DATO' MOHD ZAHIR BIN ZAHUR HUSSAIN

Mar 27 13:10

PHARMA: Change in Risk Committee - PUAN SARAH AZREEN BINTI ABDUL SAMAT

Mar 27 13:10

PHARMA: Change in Nomination and Remuneration Committee - DATO' DR FARIDAH ARYANI BINTI MD YUSOF

Mar 27 13:07

PHARMA: Change in Nomination and Remuneration Committee - TUAN DRS. IMAM FATHORRAHMAN

Mar 27 13:07

PHARMA: PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT

Mar 4 18:03

Forbid of Direct Business Transaction (DBT) Due to Rule 10.10(3)

Feb 29 14:02